{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:55:45Z","timestamp":1773104145757,"version":"3.50.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007137","name":"Helse Nord RHF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Transcatheter aortic valve implantation (TAVI) has become a standard treatment option for patients with symptomatic aortic stenosis. Elderly high-risk patients treated with TAVI have a high residual mortality due to preexisting comorbidities. Knowledge of factors predicting futility after TAVI is sparse and clinical tools to aid the preoperative evaluation are lacking. The aim of this study was to evaluate if echocardiographic measures, including speckle-tracking analysis, in addition to clinical parameters, could aid in the prediction of mortality beyond 30 days after TAVI.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This prospective observational cohort study included 227 patients treated with TAVI at the University Hospital of North Norway, Troms\u00f8 and Oslo University Hospital, Rikshospitalet from February 2010 to June 2013. All the patients underwent preoperative echocardiographic evaluation with retrospective speckle-tracking analysis. Primary endpoints were 1- and 2-year mortality beyond 30 days after TAVI.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> All-cause 1- and 2-year mortality beyond 30 days after TAVI was 12.1 and 19.5%, respectively. Predictors of 1-year mortality beyond 30 days were body mass index [hazard ratio (HR): 0.88, 95% CI: 0.80\u20130.98, <jats:italic>p<\/jats:italic> = 0.018], previous myocardial infarction (HR: 2.69, 95% CI: 1.14\u20136.32, <jats:italic>p<\/jats:italic> = 0.023), and systolic pulmonary artery pressure \u2265 60 mm Hg (HR: 5.93, 95% CI: 1.67\u201321.1, <jats:italic>p<\/jats:italic> = 0.006). Moderate-to-severe mitral regurgitation (HR: 2.93, 95% CI: 1.53\u20135.63, <jats:italic>p<\/jats:italic> = 0.001), estimated glomerular filtration rate (HR: 0.98, 95% CI: 0.96\u20130.99, <jats:italic>p<\/jats:italic> = 0.002), and chronic obstructive pulmonary disease (HR: 1.9, 95% CI: 1.01\u20133.58, <jats:italic>p<\/jats:italic> = 0.046) were predictors of 2-year mortality.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Both the clinical and echocardiographic parameters should be considered when evaluating high-risk patients for TAVI, as both are predictive of 1-and 2-year mortality. Our results support the importance of individual risk assessment using a multidisciplinary, multimodal, and individual approach.<\/jats:p>","DOI":"10.3389\/fcvm.2021.739710","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T05:13:20Z","timestamp":1638767600000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical and Echocardiographic Parameters Predicting 1- and 2-Year Mortality After Transcatheter Aortic Valve Implantation"],"prefix":"10.3389","volume":"8","author":[{"given":"Didrik","family":"Kj\u00f8n\u00e5s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Schirmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svend","family":"Aakhus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Eidet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siri","family":"Malm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Aaberge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Busund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assami","family":"R\u00f6sner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1016\/j.rec.2017.12.013","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Euro Heart J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.amjcard.2012.11.056","article-title":"Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement","volume":"111","author":"Durand","year":"2013","journal-title":"Am J Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2459\/JCM.0b013e3283638e26","article-title":"Inaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacement","volume":"14","author":"D'Ascenzo","year":"2013","journal-title":"J Cardiovasc Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.114.009834","article-title":"Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy","volume":"130","author":"Kapadia","year":"2014","journal-title":"Circulation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/S0735-1097(12)60011-4","article-title":"Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the canadian multicenter experience","volume":"60","author":"Rod\u00e9s-Cabau","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.4244\/EIJV8I7A121","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantationthe valve academic research consortium-2 consensus document\u2020","volume":"60","author":"Kappetein","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e000936","DOI":"10.1136\/openhrt-2018-000936","article-title":"Predictors of early mortality after transcatheter aortic valve implantation","volume":"6","author":"Kj\u00f8n\u00e5s","year":"2019","journal-title":"Open Heart."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1161\/CIRCULATIONAHA.114.013947","article-title":"Transcatheter aortic valve implantation in the United Kingdom. Temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK transcatheter aortic valve implantation (TAVI) Registry, 2007 to 2012","volume":"131","author":"Ludman","year":"2015","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.amjcard.2013.03.024","article-title":"Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis","volume":"112","author":"Zahn","year":"2013","journal-title":"Am J Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.jacc.2016.07.747","article-title":"Late outcomes of transcatheter aortic valve replacement in high-risk patients: the FRANCE-2 registry","volume":"68","author":"Gilard","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/CIRCINTERVENTIONS.113.000482","article-title":"Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. Study from the FRANCE 2 registry","volume":"7","author":"Lu\u00e7on","year":"2014","journal-title":"Circulation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.amjcard.2015.02.022","article-title":"Prevalence and impact of pulmonary hypertension on patients with aortic stenosis who underwent transcatheter aortic valve replacement","volume":"115","author":"Barbash","year":"2015","journal-title":"Am J Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e002358","DOI":"10.1161\/CIRCINTERVENTIONS.114.002358","article-title":"Effect of pulmonary hypertension hemodynamic presentation on clinical outcomes in patients with severe symptomatic aortic valve stenosis undergoing transcatheter aortic valve implantation","volume":"8","author":"O'Sullivan","year":"2015","journal-title":"Circulation."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1136\/heartjnl-2014-307120","article-title":"Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis","volume":"101","author":"Nombela-Franco","year":"2015","journal-title":"Heart."},{"key":"B19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/heartjnl-2017-311552","article-title":"Mitral regurgitation in patients with severe aortic stenosis: diagnosis and management","volume":"104","author":"Sannino","year":"2018","journal-title":"Heart."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1169","DOI":"10.4244\/EIJ-D-18-00098","article-title":"Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results","volume":"14","author":"D'ascenzo","year":"2018","journal-title":"EuroIntervention."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e006092","DOI":"10.1161\/JAHA.117.006092","article-title":"Impact of coronary artery disease on 30-day and 1-year mortality in patients undergoing transcatheter aortic valve replacement: a meta-analysis","volume":"6","author":"Sankaramangalam","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa1114705","article-title":"Registry of transcatheter aortic-valve implantation in high-risk patients","volume":"366","author":"Gilard","year":"2012","journal-title":"N Engl J Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jcin.2013.04.015","article-title":"Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice","volume":"6","author":"Van Mieghem","year":"2013","journal-title":"JACC Cardiovasc Interventions."},{"key":"B24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jacc.2013.09.024","article-title":"Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER Trial (Placement of AoRTic TraNscathetER Valve)","volume":"63","author":"Dvir","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.jcin.2013.06.008","article-title":"Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes","volume":"6","author":"Mok","year":"2013","journal-title":"JACC Cardiovasc Interventions."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0119817","DOI":"10.1371\/journal.pone.0119817","article-title":"Impact of renal dysfunction on mid-term outcome after transcatheter aortic valve implantation: a systematic review and meta-analysis","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS ONE."},{"key":"B27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jacc.2017.06.024","article-title":"Frailty in older adults undergoing aortic valve replacement: the FRAILTY-AVR study","volume":"70","author":"Afilalo","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e022543","DOI":"10.1136\/bmjopen-2018-022543","article-title":"Do frailty measures improve prediction of mortality and morbidity following transcatheter aortic valve implantation? An analysis of the UK TAVI registry","volume":"8","author":"Martin","year":"2018","journal-title":"BMJ Open."},{"key":"B29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2015.12.003","article-title":"Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments","volume":"26","author":"Buta","year":"2016","journal-title":"Ageing Res Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol Ser A."},{"key":"B31","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/icvts\/ivx191","article-title":"The \u2018obesity paradox\u2019 does exist in patients undergoing transcatheter aortic valve implantation for aortic stenosis: a systematic review and meta-analysis","volume":"25","author":"Lv","year":"2017","journal-title":"Interactive CardioVascular Thoracic Surg."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","author":"Vahanian","year":"2021","journal-title":"Euro Heart J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.739710\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T05:13:23Z","timestamp":1638767603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.739710\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":33,"alternative-id":["10.3389\/fcvm.2021.739710"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.739710","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,6]]},"article-number":"739710"}}